Literature DB >> 22011173

Thinking about dried blood spots for pharmacokinetic assays and therapeutic drug monitoring.

Peter T Kissinger1.   

Abstract

Mesh:

Substances:

Year:  2011        PMID: 22011173     DOI: 10.4155/bio.11.235

Source DB:  PubMed          Journal:  Bioanalysis        ISSN: 1757-6180            Impact factor:   2.681


× No keyword cloud information.
  5 in total

1.  One mouse, one pharmacokinetic profile: quantitative whole blood serial sampling for biotherapeutics.

Authors:  Alison P Joyce; Mengmeng Wang; Rosemary Lawrence-Henderson; Cynthia Filliettaz; Sheldon S Leung; Xin Xu; Denise M O'Hara
Journal:  Pharm Res       Date:  2014-01-24       Impact factor: 4.200

2.  Validation and Application of a Dried Blood Spot Ceftriaxone Assay.

Authors:  Madhu Page-Sharp; Troy Nunn; Sam Salman; Brioni R Moore; Kevin T Batty; Timothy M E Davis; Laurens Manning
Journal:  Antimicrob Agents Chemother       Date:  2015-10-05       Impact factor: 5.191

3.  Determination of ethyl glucuronide and ethyl sulfate from dried blood spots.

Authors:  Ana Hernández Redondo; Alexandra Schroeck; Beat Kneubuehl; Wolfgang Weinmann
Journal:  Int J Legal Med       Date:  2013-01-03       Impact factor: 2.686

4.  Dried blood sample analysis by antibody array across the total testing process.

Authors:  Kelly Whittaker; Ying-Qing Mao; Yongping Lin; Huihua Zhang; Siwei Zhu; Hannah Peck; Ruo-Pan Huang
Journal:  Sci Rep       Date:  2021-10-15       Impact factor: 4.379

5.  Comparison of a Blood Self-Collection System with Routine Phlebotomy for SARS-CoV-2 Antibody Testing.

Authors:  Douglas Wixted; Coralei E Neighbors; Carl F Pieper; Angie Wu; Carla Kingsbury; Heidi Register; Elizabeth Petzold; L Kristin Newby; Christopher W Woods
Journal:  Diagnostics (Basel)       Date:  2022-07-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.